Back to search

Aristotle University Of Thessaloniki (AUTH)

Φαρμακευτική αντιμετώπιση της στυτικής δυσλειτουργίας: συγκριτική μελέτη των αναστολέων φωσφοδιεστεράσης τύπου 5 (PDE-5 inhibitors)

Abstract

dc:description

OBJECTIVES: To investigate the efficacy, the tolerability and the side effects of the three known oral PDE5 inhibitors (Sildnafil, vardenafil HCL, tadalafil) and if these parameters are influenced by specific patients’ characteristics. PATIENTS AND METHODS: 187 patients with ED were participated in the study. All of them completed the IIEF questionnaire following by a detailed medical and psychological history. Baseline variables examined were age, body mass index, alcohol consumption, smoking status, physical activity, ED aetiology/duration, comorbidities in medical history, medication intake, psychological status and baseline scores for the IIEF domains. After a 4 weeks screening period, they received all three PDE5 inhibitors with incidental sequence. The maximum dose was used (Sildenafil 100mg, Vardenafil 20mg, Tadalafil 20mg) for at least 4 attempts for intercourse with each one of them (4 pills from each drug) during a 4-weeks period. In every follow up visit, the Sexual encounter Profile (SEP) diary were selected and the IIEF questionnaire was completed. A week wash out period was followed after each of the 3 treatment period. General linear model repeated measures ANOVA controlled were used to determine if any baseline characteristics were associated with the efficacy, tolerability and patients’ preference. Post-baseline variables examined were differences in IIEF domains, SEP scores and the presence of side-effects. RESULTS: 102 patients completed the three treatments period and included in the analysis. Participants' IIEF scores were significantly lower at the baseline compared to the other 3 visits irrespective of the drug taken. Only for the ED-subscale there was a significant difference (p<0.01) between sildenafil use and tadalafil use, as the study sample had slightly lower IIEF score using sildelafil compared to the treatment period using tadalafil. All the baseline variables influenced the behaviour of PDE5 inhibitors at least at one of the subscales of the IIEF questionnaire. In addition, there were differences between two PDE5 inhibitors in the same patient depending on special conditions, such as alcohol consumption or ED duration. SEP scores confirmed the IIEF answers by each patient showing preference to the substance which improved more the hardness, the duration and the number of sexual attempts. CONCLUSION: We identified that baseline characteristics can influence the efficacy, tolerability and patient’s satisfaction. Tadalafil seems to give better results and fewer side effects than sildenafil. Despite their similarity in way of acting, the three PDE5 inhibitors have differences and patient can distinguish these and prefer one or the other depending on his ‘profit’.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Toutziaris, Chrysovalantis
  • Τουτζιάρης, Χρυσοβαλάντης

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19497

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Toutziaris, Chrysovalantis; Τουτζιάρης, Χρυσοβαλάντης. Φαρμακευτική αντιμετώπιση της στυτικής δυσλειτουργίας: συγκριτική μελέτη των αναστολέων φωσφοδιεστεράσης τύπου 5 (PDE-5 inhibitors). Aristotle University Of Thessaloniki (AUTH), 2009. http://hdl.handle.net/10442/hedi/19497